Filter
244
Text search:
dexaméthasone
Featured
Recommendations
42
New Publications
54
Language
Document type
No document type
110
Guidelines
80
Studies & Reports
23
Manuals
11
Training Material
7
Fact sheets
5
Strategic & Response Plan
4
Resource Platforms
2
Situation Updates
1
Infographics
1
Countries / Regions
India
27
Ethiopia
9
Nepal
8
Kenya
8
Rwanda
7
Germany
5
Indonesia
5
South Africa
5
Mozambique
5
Global
5
Guinea-Bissau
4
Uganda
4
Bangladesh
4
Brazil
4
Angola
4
Latin America and the Carribbean
4
Liberia
3
Nigeria
3
Cameroon
3
Tanzania
3
Myanmar / Burma
3
West and Central Africa
3
Russia
3
Senegal
2
Congo, Democratic Republic of
2
Ghana
2
Zimbabwe
2
Haiti
2
South Sudan
2
Zambia
2
Syria
2
Malawi
2
Argentina
2
Namibia
2
East and Southern Africa
2
Middle East and North Africa
2
Africa
2
Guinea
1
Burkina Faso
1
Sierra Leone
1
Mali
1
Côte d’Ivoire / Ivory Coast
1
Philippines
1
Cambodia
1
Gambia
1
Malaysia
1
Eswatini/ Swaziland
1
Botswana
1
Libya
1
Madagascar
1
Yemen
1
Eastern Europe and Central Asia
1
Paraguay
1
Fiji
1
Solomon Islands
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Countries
138
Clinical Guidelines
40
Women & Child Health
15
Key Resources
4
Public Health
3
Pharmacy & Technologies
2
Toolboxes
COVID-19
55
Pharmacy
27
TB
14
Mental Health
8
HIV
5
AMR
5
Conflict
4
NTDs
4
Global Health Education
3
Caregiver
3
Rapid Response
2
Planetary Health
2
Malaria
2
Disability
1
Ebola & Marburg
1
Health Financing Toolbox
1
NCDs
1
Second Edition, 2012
The primary audience for this guideline includes health-care professionals who are responsible for developing national and local health-care protocols and policies, as well as managers of maternal and child health programmes and policy-makers in all settings. The guideline will also be useful to tho
...
Resource platform
The information provided here can be used to understand the current situation, increase attention to preterm births in Rwanda and to inform dialogue and action among stakeholders. Data can be used to identify the most important risk factors to target and gaps in care in order to identify and impleme
...
The information provided here can be used to understand the current situation, increase attention to preterm births in Rwanda and to inform dialogue and action among stakeholders. Data can be used to identify the most important risk factors to target and gaps in care in order to identify and impleme
...
Interagency Guidelines - This revised Interagency List of Essential Medicines for Reproductive Health presents
the current international consensus on rational selection of essential reproductive health medicines. The list is intended to support decisions regarding the production, quality assurance
...
Ongoing Living Update of COVID-19 Therapeutic Options: Summary of Evidence, Rapid Review 22 February 2022
recommended
This document includes the results of a rapid systematic review of current available literature. The information included in this review reflects the evidence as of the date posted in the document. In recognition of the fact that there are numerous ongoing clinical studies, PAHO will periodically up
...
The information provided here can be used to understand the current situation, increase attention to preterm births in Rwanda and to inform dialogue and action among stakeholders. Data can be used to identify the most important risk factors to target and gaps in care in order to identify and impleme
...
The information provided here can be used to understand the current situation, increase attention to preterm births in Rwanda and to inform dialogue and action among stakeholders. Data can be used to identify the most important risk factors to target and gaps in care in order to identify and impleme
...
The information provided here can be used to understand the current situation, increase attention to preterm births in Rwanda and to inform dialogue and action among stakeholders. Data can be used to identify the most important risk factors to target and gaps in care in order to identify and impleme
...
The unmet need for palliative care in Cox’s Bazar
Since the description of the first case of COVID-19 in Wuhan, Hubei province in China, in December 2019, much knowledge has been accumulated about the dynamics of evolution of the SARS-CoV-2 virus, contagion, disease progression, prevention and treatment.
In this edition, medicines used in ICU, haemodialysis and chemotherapy unit has also been added under NEML. The medicines under disinfectants and antiseptics, intrauterine devices and barrier methods under contraceptives has been deleted and moved to medical supplies and equipment list. A section
...
